Furthermore, both combinations reduced metabolic activity significantly in the DLBCL cell line SU-DHL-4 compared to the DMSO control and AZD or I-BET single agents, respectively (Figure 2b). The gene discussed is DNER; the disease is diffuse large B-cell lymphoma.